# Globe Life Inc.: financial statements, quarterly

GL · NYSE · CIK 320335 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gl.md) · [Financials](/companies/gl/financials.md) · [Filings](/companies/gl/filings.md) · [Insiders](/companies/gl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,384](/filings/0000320335-24-000060.md) | [1,416](/filings/0000320335-24-000006.md) | [1,416](/filings/0000320335-25-000032.md) | [1,440](/filings/0000320335-25-000046.md) | [1,455](/filings/0000320335-25-000064.md) | [1,466 d](/filings/0000320335-26-000090.md) | [1,480](/filings/0000320335-26-000169.md) | [1,481](/filings/0000320335-26-000216.md) | [1,513](/filings/0000320335-25-000064.md) | [1,520 d](/filings/0000320335-26-000090.md) | [1,560](/filings/0000320335-26-000169.md) | [1,600](/filings/0000320335-26-000216.md) |
| Gross profit | $m | [321](/filings/0000320335-24-000060.md) | [323 d](/filings/0000320335-24-000006.md) | [327](/filings/0000320335-24-000025.md) | [335](/filings/0000320335-24-000048.md) | [379](/filings/0000320335-24-000060.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [322](/filings/0000320335-24-000060.md) | [327 d](/filings/0000320335-24-000006.md) | [327](/filings/0000320335-24-000025.md) | [339](/filings/0000320335-24-000048.md) | [383](/filings/0000320335-24-000060.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [26.0](/filings/0000320335-24-000060.md) | [25.7 d](/filings/0000320335-26-000090.md) | [28.6](/filings/0000320335-25-000032.md) | [31.4](/filings/0000320335-25-000046.md) | [31.4](/filings/0000320335-25-000064.md) | [35.7 d](/filings/0000320335-26-000090.md) | [35.0](/filings/0000320335-26-000169.md) | [34.9](/filings/0000320335-26-000216.md) | [36.1](/filings/0000320335-25-000064.md) | [35.2 d](/filings/0000320335-26-000090.md) | [34.0](/filings/0000320335-26-000169.md) | [36.1](/filings/0000320335-26-000216.md) |
| Income tax | $m | [61.7](/filings/0000320335-24-000060.md) | [61.9 d](/filings/0000320335-26-000090.md) | [60.7](/filings/0000320335-25-000032.md) | [64.0](/filings/0000320335-25-000046.md) | [74.0](/filings/0000320335-25-000064.md) | [57.2 d](/filings/0000320335-26-000090.md) | [61.5](/filings/0000320335-26-000169.md) | [60.6](/filings/0000320335-26-000216.md) | [89.3](/filings/0000320335-25-000064.md) | [63.4 d](/filings/0000320335-26-000090.md) | [63.6](/filings/0000320335-26-000169.md) | [67.1](/filings/0000320335-26-000216.md) |
| Net income | $m | [257](/filings/0000320335-24-000060.md) | [275](/filings/0000320335-24-000006.md) | [254](/filings/0000320335-25-000032.md) | [258](/filings/0000320335-25-000046.md) | [303](/filings/0000320335-25-000064.md) | [255 d](/filings/0000320335-26-000090.md) | [255](/filings/0000320335-26-000169.md) | [253](/filings/0000320335-26-000216.md) | [388](/filings/0000320335-25-000064.md) | [266 d](/filings/0000320335-26-000090.md) | [271](/filings/0000320335-26-000169.md) | [288](/filings/0000320335-26-000216.md) |
| Diluted EPS | $ per share | [2.68](/filings/0000320335-24-000060.md) | [2.88](/filings/0000320335-24-000006.md) | [2.67](/filings/0000320335-25-000032.md) | [2.83](/filings/0000320335-25-000046.md) | [3.44](/filings/0000320335-25-000064.md) | not reported | [3.01](/filings/0000320335-26-000169.md) | [3.05](/filings/0000320335-26-000216.md) | [4.73](/filings/0000320335-25-000064.md) | not reported | [3.39](/filings/0000320335-26-000169.md) | [3.65](/filings/0000320335-26-000216.md) |
| Basic EPS | $ per share | [2.72](/filings/0000320335-24-000060.md) | [2.92](/filings/0000320335-24-000006.md) | [2.71](/filings/0000320335-25-000032.md) | [2.83](/filings/0000320335-25-000046.md) | [3.45](/filings/0000320335-25-000064.md) | not reported | [3.05](/filings/0000320335-26-000169.md) | [3.09](/filings/0000320335-26-000216.md) | [4.81](/filings/0000320335-25-000064.md) | not reported | [3.45](/filings/0000320335-26-000169.md) | [3.71](/filings/0000320335-26-000216.md) |

- Revenue: us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0000320335-23-000054.md) | [0.1](/filings/0000320335-25-000013.md) | [0.1](/filings/0000320335-24-000025.md) | [0.1](/filings/0000320335-24-000048.md) | [0.1](/filings/0000320335-24-000060.md) | [0.2](/filings/0000320335-26-000090.md) | [0.2](/filings/0000320335-25-000032.md) | [0.2](/filings/0000320335-25-000046.md) | [0.3](/filings/0000320335-25-000064.md) | [0.1](/filings/0000320335-26-000216.md) | [0.3](/filings/0000320335-26-000169.md) | [0.3](/filings/0000320335-26-000216.md) |
| Total assets | $bn | [26.2](/filings/0000320335-24-000006.md) | [28.1](/filings/0000320335-25-000013.md) | [28.6](/filings/0000320335-24-000025.md) | [28.3](/filings/0000320335-24-000048.md) | [29.6](/filings/0000320335-24-000060.md) | [29.1](/filings/0000320335-26-000090.md) | [29.7](/filings/0000320335-25-000032.md) | [29.8](/filings/0000320335-25-000046.md) | [30.5](/filings/0000320335-25-000064.md) | [30.8](/filings/0000320335-26-000216.md) | [31.0](/filings/0000320335-26-000169.md) | [31.6](/filings/0000320335-26-000216.md) |
| Total liabilities | $bn | [21.6](/filings/0000320335-24-000006.md) | [23.6](/filings/0000320335-25-000013.md) | [23.5](/filings/0000320335-24-000025.md) | [23.1](/filings/0000320335-24-000048.md) | [24.9](/filings/0000320335-24-000060.md) | [23.8](/filings/0000320335-26-000090.md) | [24.3](/filings/0000320335-25-000032.md) | [24.4](/filings/0000320335-25-000046.md) | [24.8](/filings/0000320335-25-000064.md) | [24.8](/filings/0000320335-26-000216.md) | [24.9](/filings/0000320335-26-000169.md) | [25.4](/filings/0000320335-26-000216.md) |
| Long-term debt | $bn | [1.8](/filings/0000320335-23-000054.md) | [1.6](/filings/0000320335-25-000013.md) | [1.6](/filings/0000320335-24-000025.md) | [1.6](/filings/0000320335-24-000048.md) | [2.3](/filings/0000320335-24-000060.md) | [2.3](/filings/0000320335-26-000090.md) | [2.3](/filings/0000320335-25-000032.md) | [2.3](/filings/0000320335-25-000046.md) | [2.3](/filings/0000320335-25-000064.md) | [2.3](/filings/0000320335-26-000216.md) | [2.3](/filings/0000320335-26-000169.md) | [2.7](/filings/0000320335-26-000216.md) |
| Current portion of debt | $bn | [0.0](/filings/0000320335-23-000054.md) | [0.0](/filings/0000320335-24-000006.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.4](/filings/0000320335-23-000054.md) | [0.5](/filings/0000320335-25-000013.md) | [0.7](/filings/0000320335-24-000025.md) | [0.7](/filings/0000320335-24-000048.md) | [0.4](/filings/0000320335-24-000060.md) | [0.4](/filings/0000320335-26-000090.md) | [0.5](/filings/0000320335-25-000032.md) | [0.5](/filings/0000320335-25-000046.md) | [0.4](/filings/0000320335-25-000064.md) | [0.3](/filings/0000320335-26-000216.md) | [0.5](/filings/0000320335-26-000169.md) | [0.3](/filings/0000320335-26-000216.md) |
| Shareholders' equity | $bn | [4.6](/filings/0000320335-24-000060.md) | [4.5](/filings/0000320335-26-000090.md) | [5.0](/filings/0000320335-25-000064.md) | [5.2](/filings/0000320335-25-000064.md) | [4.6](/filings/0000320335-25-000064.md) | [5.3](/filings/0000320335-26-000216.md) | [5.4](/filings/0000320335-26-000216.md) | [5.4](/filings/0000320335-26-000216.md) | [5.7](/filings/0000320335-25-000064.md) | [6.0](/filings/0000320335-26-000216.md) | [6.1](/filings/0000320335-26-000216.md) | [6.2](/filings/0000320335-26-000216.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [287 d](/filings/0000320335-24-000060.md) | [391 d](/filings/0000320335-26-000090.md) | [351](/filings/0000320335-25-000032.md) | [374 d](/filings/0000320335-25-000046.md) | [341 d](/filings/0000320335-25-000064.md) | [337 d](/filings/0000320335-26-000090.md) | [432](/filings/0000320335-26-000169.md) | [308 d](/filings/0000320335-26-000216.md) | [306 d](/filings/0000320335-25-000064.md) | [351 d](/filings/0000320335-26-000090.md) | [421](/filings/0000320335-26-000169.md) | [314 d](/filings/0000320335-26-000216.md) |
| Capital expenditure | $m | [10.8 d](/filings/0000320335-24-000060.md) | [13.1 d](/filings/0000320335-26-000090.md) | [9.1](/filings/0000320335-25-000032.md) | [17.6 d](/filings/0000320335-25-000046.md) | [29.3 d](/filings/0000320335-25-000064.md) | [15.0 d](/filings/0000320335-26-000090.md) | [11.7](/filings/0000320335-26-000169.md) | [12.9 d](/filings/0000320335-26-000216.md) | [97.3 d](/filings/0000320335-25-000064.md) | [20.5 d](/filings/0000320335-26-000090.md) | [24.9](/filings/0000320335-26-000169.md) | [16.5 d](/filings/0000320335-26-000216.md) |
| Dividends paid | $m | [21.4 d](/filings/0000320335-24-000060.md) | [21.2 d](/filings/0000320335-26-000090.md) | [21.1](/filings/0000320335-25-000032.md) | [22.6 d](/filings/0000320335-25-000046.md) | [21.6 d](/filings/0000320335-25-000064.md) | [20.2 d](/filings/0000320335-26-000090.md) | [20.1](/filings/0000320335-26-000169.md) | [22.4 d](/filings/0000320335-26-000216.md) | [21.9 d](/filings/0000320335-25-000064.md) | [21.7 d](/filings/0000320335-26-000090.md) | [21.4](/filings/0000320335-26-000169.md) | [25.7 d](/filings/0000320335-26-000216.md) |
| Share repurchases | $m | [96.9 d](/filings/0000320335-24-000060.md) | [145 d](/filings/0000320335-26-000090.md) | [23.5](/filings/0000320335-25-000032.md) | [336 d](/filings/0000320335-25-000046.md) | [591 d](/filings/0000320335-25-000064.md) | [51.7 d](/filings/0000320335-26-000090.md) | [265](/filings/0000320335-26-000169.md) | [250 d](/filings/0000320335-26-000216.md) | [174 d](/filings/0000320335-25-000064.md) | [192 d](/filings/0000320335-26-000090.md) | [240](/filings/0000320335-26-000169.md) | [275 d](/filings/0000320335-26-000216.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [98.1](/filings/0000320335-23-000054.md) | [97.9](/filings/0000320335-24-000025.md) | [96.3](/filings/0000320335-24-000048.md) | [95.8](/filings/0000320335-24-000060.md) | [95.1](/filings/0000320335-25-000032.md) | [91.4](/filings/0000320335-25-000046.md) | [88.1](/filings/0000320335-25-000064.md) | [84.5](/filings/0000320335-26-000169.md) | [82.8](/filings/0000320335-26-000216.md) | [82.0](/filings/0000320335-25-000064.md) | [79.7](/filings/0000320335-26-000169.md) | [78.9](/filings/0000320335-26-000216.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 76,849,447 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000320335-26-000216.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.